All lobbying filings

Jim Massie & Partners, LLC

Jim Massie & Partners, LLC filed a Q4 report for Council on Radionuclides and Radiopharmaceuticals on January 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Council on Radionuclides and Radiopharmaceuticals · Trade association representing the radionuclide and radiopharmaceutical industry.

As filed: JIM MASSIE & PARTNERS, LLC for COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS.

All filings by Jim Massie & Partners, LLC · Everything Council on Radionuclides and Radiopharmaceuticals has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Energy/Nuclear

Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production Legislation impacting the production and distribution of radiopharmaceuticals S.1241 - Sanctioning Russia Act of 2025

Trade (domestic/foreign)

Issues related to the impact of tariffs on the availability of industrial and medical isotopes.

Bills named in this filing 1

S. 1241
Sanctioning Russia Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.